Clinical Trial for the Investigational Drug (PB-201) in Subjects With Type 2 Diabetes Mellitus

Clinical trial NCT03973515 · COMPLETED

Trial details

NCT number: NCT03973515
Sponsor: PegBio Co., Ltd.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Type2 Diabetes Mellitus

Start date: 2019-08-27
Primary completion: 2019-12-19
Enrollment: 16

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.